nodes	percent_of_prediction	percent_of_DWPC	metapath
Toremifene—CYP1A2—Sorafenib—thyroid cancer	0.108	0.243	CbGbCtD
Toremifene—ABCB1—Sorafenib—thyroid cancer	0.0941	0.212	CbGbCtD
Toremifene—CYP3A4—Vandetanib—thyroid cancer	0.0936	0.211	CbGbCtD
Toremifene—Keratopathy—Vandetanib—thyroid cancer	0.0592	0.118	CcSEcCtD
Toremifene—ABCB1—Doxorubicin—thyroid cancer	0.0571	0.129	CbGbCtD
Toremifene—CYP3A4—Sorafenib—thyroid cancer	0.0564	0.127	CbGbCtD
Toremifene—CYP3A4—Doxorubicin—thyroid cancer	0.0342	0.0772	CbGbCtD
Toremifene—Corneal opacity—Vandetanib—thyroid cancer	0.0307	0.061	CcSEcCtD
Toremifene—Polyp—Vandetanib—thyroid cancer	0.0132	0.0262	CcSEcCtD
Toremifene—Cyst—Vandetanib—thyroid cancer	0.012	0.0238	CcSEcCtD
Toremifene—Hypercalcaemia—Vandetanib—thyroid cancer	0.0115	0.0229	CcSEcCtD
Toremifene—Glaucoma—Vandetanib—thyroid cancer	0.0106	0.0212	CcSEcCtD
Toremifene—Embolism—Sorafenib—thyroid cancer	0.00841	0.0167	CcSEcCtD
Toremifene—Cataract—Vandetanib—thyroid cancer	0.00841	0.0167	CcSEcCtD
Toremifene—Dry eye—Vandetanib—thyroid cancer	0.00739	0.0147	CcSEcCtD
Toremifene—Cardiac failure—Vandetanib—thyroid cancer	0.00596	0.0118	CcSEcCtD
Toremifene—Lethargy—Vandetanib—thyroid cancer	0.00593	0.0118	CcSEcCtD
Toremifene—Leukorrhea—Epirubicin—thyroid cancer	0.00426	0.00847	CcSEcCtD
Toremifene—Hepatobiliary disease—Vandetanib—thyroid cancer	0.00424	0.00843	CcSEcCtD
Toremifene—Cardiac failure—Sorafenib—thyroid cancer	0.00402	0.00799	CcSEcCtD
Toremifene—Leukorrhea—Doxorubicin—thyroid cancer	0.00394	0.00784	CcSEcCtD
Toremifene—Visual impairment—Vandetanib—thyroid cancer	0.00387	0.00771	CcSEcCtD
Toremifene—Eye disorder—Vandetanib—thyroid cancer	0.00376	0.00748	CcSEcCtD
Toremifene—ESR1—Signaling mediated by p38-alpha and p38-beta—KRT19—thyroid cancer	0.00373	0.0687	CbGpPWpGaD
Toremifene—Mood swings—Sorafenib—thyroid cancer	0.00371	0.00739	CcSEcCtD
Toremifene—Angiopathy—Vandetanib—thyroid cancer	0.00365	0.00726	CcSEcCtD
Toremifene—Mediastinal disorder—Vandetanib—thyroid cancer	0.00362	0.00721	CcSEcCtD
Toremifene—Arrhythmia—Vandetanib—thyroid cancer	0.00359	0.00715	CcSEcCtD
Toremifene—Alopecia—Vandetanib—thyroid cancer	0.00355	0.00707	CcSEcCtD
Toremifene—Breast disorder—Sorafenib—thyroid cancer	0.00354	0.00705	CcSEcCtD
Toremifene—Mental disorder—Vandetanib—thyroid cancer	0.00352	0.00701	CcSEcCtD
Toremifene—Malnutrition—Vandetanib—thyroid cancer	0.0035	0.00696	CcSEcCtD
Toremifene—Vision blurred—Vandetanib—thyroid cancer	0.0033	0.00656	CcSEcCtD
Toremifene—Vaginal discharge—Epirubicin—thyroid cancer	0.00328	0.00653	CcSEcCtD
Toremifene—Polyp—Epirubicin—thyroid cancer	0.00328	0.00653	CcSEcCtD
Toremifene—Tremor—Vandetanib—thyroid cancer	0.00328	0.00652	CcSEcCtD
Toremifene—Embolism—Epirubicin—thyroid cancer	0.00311	0.00619	CcSEcCtD
Toremifene—Vaginal discharge—Doxorubicin—thyroid cancer	0.00304	0.00604	CcSEcCtD
Toremifene—Polyp—Doxorubicin—thyroid cancer	0.00304	0.00604	CcSEcCtD
Toremifene—Cyst—Epirubicin—thyroid cancer	0.00299	0.00594	CcSEcCtD
Toremifene—Chest pain—Vandetanib—thyroid cancer	0.00298	0.00593	CcSEcCtD
Toremifene—Acute coronary syndrome—Sorafenib—thyroid cancer	0.00298	0.00593	CcSEcCtD
Toremifene—Neuropathy peripheral—Sorafenib—thyroid cancer	0.00296	0.00589	CcSEcCtD
Toremifene—Myocardial infarction—Sorafenib—thyroid cancer	0.00296	0.00589	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00296	0.00589	CcSEcCtD
Toremifene—Jaundice—Sorafenib—thyroid cancer	0.00294	0.00586	CcSEcCtD
Toremifene—Embolism—Doxorubicin—thyroid cancer	0.00288	0.00572	CcSEcCtD
Toremifene—Hypercalcaemia—Epirubicin—thyroid cancer	0.00287	0.00572	CcSEcCtD
Toremifene—Hepatobiliary disease—Sorafenib—thyroid cancer	0.00286	0.00568	CcSEcCtD
Toremifene—Oedema—Vandetanib—thyroid cancer	0.00286	0.00568	CcSEcCtD
Toremifene—Thrombosis—Epirubicin—thyroid cancer	0.00282	0.00561	CcSEcCtD
Toremifene—Nervous system disorder—Vandetanib—thyroid cancer	0.0028	0.00557	CcSEcCtD
Toremifene—Thrombocytopenia—Vandetanib—thyroid cancer	0.0028	0.00556	CcSEcCtD
Toremifene—Skin disorder—Vandetanib—thyroid cancer	0.00277	0.00552	CcSEcCtD
Toremifene—Cyst—Doxorubicin—thyroid cancer	0.00276	0.0055	CcSEcCtD
Toremifene—Vaginal haemorrhage—Epirubicin—thyroid cancer	0.0027	0.00536	CcSEcCtD
Toremifene—Hypercalcaemia—Doxorubicin—thyroid cancer	0.00266	0.00529	CcSEcCtD
Toremifene—Thrombosis—Doxorubicin—thyroid cancer	0.00261	0.00519	CcSEcCtD
Toremifene—Insomnia—Vandetanib—thyroid cancer	0.00258	0.00514	CcSEcCtD
Toremifene—Dyspnoea—Vandetanib—thyroid cancer	0.00255	0.00507	CcSEcCtD
Toremifene—Vaginal haemorrhage—Doxorubicin—thyroid cancer	0.0025	0.00496	CcSEcCtD
Toremifene—Decreased appetite—Vandetanib—thyroid cancer	0.00248	0.00494	CcSEcCtD
Toremifene—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00247	0.00491	CcSEcCtD
Toremifene—Fatigue—Vandetanib—thyroid cancer	0.00246	0.0049	CcSEcCtD
Toremifene—Angiopathy—Sorafenib—thyroid cancer	0.00246	0.0049	CcSEcCtD
Toremifene—Rigors—Epirubicin—thyroid cancer	0.00244	0.00486	CcSEcCtD
Toremifene—Mediastinal disorder—Sorafenib—thyroid cancer	0.00244	0.00486	CcSEcCtD
Toremifene—Pain—Vandetanib—thyroid cancer	0.00244	0.00486	CcSEcCtD
Toremifene—Constipation—Vandetanib—thyroid cancer	0.00244	0.00486	CcSEcCtD
Toremifene—Arrhythmia—Sorafenib—thyroid cancer	0.00242	0.00482	CcSEcCtD
Toremifene—Alopecia—Sorafenib—thyroid cancer	0.0024	0.00477	CcSEcCtD
Toremifene—ESR1—Nuclear Receptors—THRB—thyroid cancer	0.00239	0.0441	CbGpPWpGaD
Toremifene—ESR1—Regulation of nuclear SMAD2/3 signaling—CITED1—thyroid cancer	0.00238	0.0439	CbGpPWpGaD
Toremifene—Mental disorder—Sorafenib—thyroid cancer	0.00238	0.00473	CcSEcCtD
Toremifene—Malnutrition—Sorafenib—thyroid cancer	0.00236	0.0047	CcSEcCtD
Toremifene—Rigors—Doxorubicin—thyroid cancer	0.00226	0.0045	CcSEcCtD
Toremifene—Skin discolouration—Epirubicin—thyroid cancer	0.00221	0.0044	CcSEcCtD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—RET—thyroid cancer	0.00221	0.0407	CbGpPWpGaD
Toremifene—Leukopenia—Sorafenib—thyroid cancer	0.00211	0.0042	CcSEcCtD
Toremifene—Asthenia—Vandetanib—thyroid cancer	0.00205	0.00408	CcSEcCtD
Toremifene—Skin discolouration—Doxorubicin—thyroid cancer	0.00204	0.00407	CcSEcCtD
Toremifene—Coordination abnormal—Epirubicin—thyroid cancer	0.00203	0.00404	CcSEcCtD
Toremifene—Pruritus—Vandetanib—thyroid cancer	0.00202	0.00402	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.002	0.00397	CcSEcCtD
Toremifene—Hepatocellular injury—Epirubicin—thyroid cancer	0.002	0.00397	CcSEcCtD
Toremifene—Pulmonary embolism—Epirubicin—thyroid cancer	0.002	0.00397	CcSEcCtD
Toremifene—ESR1—Nuclear Receptor transcription pathway—THRB—thyroid cancer	0.00189	0.0348	CbGpPWpGaD
Toremifene—Nervous system disorder—Sorafenib—thyroid cancer	0.00189	0.00376	CcSEcCtD
Toremifene—Dizziness—Vandetanib—thyroid cancer	0.00189	0.00376	CcSEcCtD
Toremifene—Thrombocytopenia—Sorafenib—thyroid cancer	0.00189	0.00375	CcSEcCtD
Toremifene—Coordination abnormal—Doxorubicin—thyroid cancer	0.00188	0.00374	CcSEcCtD
Toremifene—Skin disorder—Sorafenib—thyroid cancer	0.00187	0.00372	CcSEcCtD
Toremifene—Pulmonary embolism—Doxorubicin—thyroid cancer	0.00185	0.00367	CcSEcCtD
Toremifene—Hepatocellular injury—Doxorubicin—thyroid cancer	0.00185	0.00367	CcSEcCtD
Toremifene—Dry eye—Epirubicin—thyroid cancer	0.00184	0.00367	CcSEcCtD
Toremifene—Anorexia—Sorafenib—thyroid cancer	0.00184	0.00365	CcSEcCtD
Toremifene—Vomiting—Vandetanib—thyroid cancer	0.00182	0.00361	CcSEcCtD
Toremifene—Rash—Vandetanib—thyroid cancer	0.0018	0.00358	CcSEcCtD
Toremifene—Dermatitis—Vandetanib—thyroid cancer	0.0018	0.00358	CcSEcCtD
Toremifene—Headache—Vandetanib—thyroid cancer	0.00179	0.00356	CcSEcCtD
Toremifene—Abnormal vision—Epirubicin—thyroid cancer	0.00174	0.00346	CcSEcCtD
Toremifene—Dyspnoea—Sorafenib—thyroid cancer	0.00172	0.00342	CcSEcCtD
Toremifene—Dry eye—Doxorubicin—thyroid cancer	0.00171	0.00339	CcSEcCtD
Toremifene—Nausea—Vandetanib—thyroid cancer	0.0017	0.00338	CcSEcCtD
Toremifene—Decreased appetite—Sorafenib—thyroid cancer	0.00167	0.00333	CcSEcCtD
Toremifene—Thrombophlebitis—Epirubicin—thyroid cancer	0.00167	0.00333	CcSEcCtD
Toremifene—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00166	0.00331	CcSEcCtD
Toremifene—Fatigue—Sorafenib—thyroid cancer	0.00166	0.00331	CcSEcCtD
Toremifene—Constipation—Sorafenib—thyroid cancer	0.00165	0.00328	CcSEcCtD
Toremifene—Pain—Sorafenib—thyroid cancer	0.00165	0.00328	CcSEcCtD
Toremifene—Abnormal vision—Doxorubicin—thyroid cancer	0.00161	0.0032	CcSEcCtD
Toremifene—Hot flush—Epirubicin—thyroid cancer	0.00155	0.00308	CcSEcCtD
Toremifene—Thrombophlebitis—Doxorubicin—thyroid cancer	0.00155	0.00308	CcSEcCtD
Toremifene—Menopausal symptoms—Epirubicin—thyroid cancer	0.00154	0.00305	CcSEcCtD
Toremifene—CYP1A1—Arachidonic acid metabolism—HPGD—thyroid cancer	0.0015	0.0276	CbGpPWpGaD
Toremifene—Cardiac failure—Epirubicin—thyroid cancer	0.00148	0.00295	CcSEcCtD
Toremifene—Lethargy—Epirubicin—thyroid cancer	0.00148	0.00294	CcSEcCtD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—RET—thyroid cancer	0.00146	0.0269	CbGpPWpGaD
Toremifene—Diplopia—Epirubicin—thyroid cancer	0.00145	0.00288	CcSEcCtD
Toremifene—Hot flush—Doxorubicin—thyroid cancer	0.00143	0.00285	CcSEcCtD
Toremifene—Affect lability—Epirubicin—thyroid cancer	0.00143	0.00284	CcSEcCtD
Toremifene—Menopausal symptoms—Doxorubicin—thyroid cancer	0.00142	0.00283	CcSEcCtD
Toremifene—Asthenia—Sorafenib—thyroid cancer	0.00138	0.00275	CcSEcCtD
Toremifene—Cardiac failure—Doxorubicin—thyroid cancer	0.00137	0.00273	CcSEcCtD
Toremifene—Mood swings—Epirubicin—thyroid cancer	0.00137	0.00273	CcSEcCtD
Toremifene—Lethargy—Doxorubicin—thyroid cancer	0.00137	0.00272	CcSEcCtD
Toremifene—Pruritus—Sorafenib—thyroid cancer	0.00136	0.00271	CcSEcCtD
Toremifene—Ataxia—Epirubicin—thyroid cancer	0.00136	0.00271	CcSEcCtD
Toremifene—Diplopia—Doxorubicin—thyroid cancer	0.00134	0.00267	CcSEcCtD
Toremifene—Liver function test abnormal—Epirubicin—thyroid cancer	0.00134	0.00266	CcSEcCtD
Toremifene—Affect lability—Doxorubicin—thyroid cancer	0.00132	0.00263	CcSEcCtD
Toremifene—Breast disorder—Epirubicin—thyroid cancer	0.00131	0.0026	CcSEcCtD
Toremifene—Dizziness—Sorafenib—thyroid cancer	0.00127	0.00253	CcSEcCtD
Toremifene—Mood swings—Doxorubicin—thyroid cancer	0.00127	0.00253	CcSEcCtD
Toremifene—Ataxia—Doxorubicin—thyroid cancer	0.00126	0.00251	CcSEcCtD
Toremifene—Liver function test abnormal—Doxorubicin—thyroid cancer	0.00124	0.00246	CcSEcCtD
Toremifene—Vomiting—Sorafenib—thyroid cancer	0.00123	0.00244	CcSEcCtD
Toremifene—Angina pectoris—Epirubicin—thyroid cancer	0.00122	0.00243	CcSEcCtD
Toremifene—Rash—Sorafenib—thyroid cancer	0.00121	0.00242	CcSEcCtD
Toremifene—Dermatitis—Sorafenib—thyroid cancer	0.00121	0.00241	CcSEcCtD
Toremifene—Breast disorder—Doxorubicin—thyroid cancer	0.00121	0.00241	CcSEcCtD
Toremifene—Headache—Sorafenib—thyroid cancer	0.00121	0.0024	CcSEcCtD
Toremifene—Nausea—Sorafenib—thyroid cancer	0.00114	0.00228	CcSEcCtD
Toremifene—Weight increased—Epirubicin—thyroid cancer	0.00114	0.00227	CcSEcCtD
Toremifene—Angina pectoris—Doxorubicin—thyroid cancer	0.00113	0.00225	CcSEcCtD
Toremifene—Neuropathy peripheral—Epirubicin—thyroid cancer	0.00109	0.00218	CcSEcCtD
Toremifene—Jaundice—Epirubicin—thyroid cancer	0.00109	0.00217	CcSEcCtD
Toremifene—Sweating—Epirubicin—thyroid cancer	0.00107	0.00213	CcSEcCtD
Toremifene—Hepatobiliary disease—Epirubicin—thyroid cancer	0.00106	0.0021	CcSEcCtD
Toremifene—Weight increased—Doxorubicin—thyroid cancer	0.00105	0.0021	CcSEcCtD
Toremifene—ESR1—Nuclear Receptors—RXRA—thyroid cancer	0.00102	0.0187	CbGpPWpGaD
Toremifene—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.00101	0.00201	CcSEcCtD
Toremifene—ESR1—FOXM1 transcription factor network—CDK1—thyroid cancer	0.00101	0.0186	CbGpPWpGaD
Toremifene—Jaundice—Doxorubicin—thyroid cancer	0.00101	0.002	CcSEcCtD
Toremifene—Sweating—Doxorubicin—thyroid cancer	0.00099	0.00197	CcSEcCtD
Toremifene—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000977	0.00194	CcSEcCtD
Toremifene—Visual impairment—Epirubicin—thyroid cancer	0.000966	0.00192	CcSEcCtD
Toremifene—CYP3A4—Liver X Receptor Pathway—RXRA—thyroid cancer	0.000964	0.0178	CbGpPWpGaD
Toremifene—CYP1A2—Arachidonic acid metabolism—HPGD—thyroid cancer	0.000955	0.0176	CbGpPWpGaD
Toremifene—Eye disorder—Epirubicin—thyroid cancer	0.000937	0.00186	CcSEcCtD
Toremifene—ESR1—Estrogen signaling pathway—BRAF—thyroid cancer	0.000934	0.0172	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—RET—thyroid cancer	0.000933	0.0172	CbGpPWpGaD
Toremifene—Angiopathy—Epirubicin—thyroid cancer	0.000909	0.00181	CcSEcCtD
Toremifene—Mediastinal disorder—Epirubicin—thyroid cancer	0.000903	0.0018	CcSEcCtD
Toremifene—Chills—Epirubicin—thyroid cancer	0.000899	0.00179	CcSEcCtD
Toremifene—Arrhythmia—Epirubicin—thyroid cancer	0.000895	0.00178	CcSEcCtD
Toremifene—Visual impairment—Doxorubicin—thyroid cancer	0.000894	0.00178	CcSEcCtD
Toremifene—Alopecia—Epirubicin—thyroid cancer	0.000886	0.00176	CcSEcCtD
Toremifene—Mental disorder—Epirubicin—thyroid cancer	0.000878	0.00175	CcSEcCtD
Toremifene—Malnutrition—Epirubicin—thyroid cancer	0.000873	0.00174	CcSEcCtD
Toremifene—Eye disorder—Doxorubicin—thyroid cancer	0.000867	0.00172	CcSEcCtD
Toremifene—ESR1—Nuclear signaling by ERBB4—NRG1—thyroid cancer	0.000861	0.0159	CbGpPWpGaD
Toremifene—Back pain—Epirubicin—thyroid cancer	0.000844	0.00168	CcSEcCtD
Toremifene—Angiopathy—Doxorubicin—thyroid cancer	0.000841	0.00167	CcSEcCtD
Toremifene—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000836	0.00166	CcSEcCtD
Toremifene—Chills—Doxorubicin—thyroid cancer	0.000832	0.00166	CcSEcCtD
Toremifene—Arrhythmia—Doxorubicin—thyroid cancer	0.000828	0.00165	CcSEcCtD
Toremifene—Vision blurred—Epirubicin—thyroid cancer	0.000822	0.00164	CcSEcCtD
Toremifene—Alopecia—Doxorubicin—thyroid cancer	0.00082	0.00163	CcSEcCtD
Toremifene—Mental disorder—Doxorubicin—thyroid cancer	0.000813	0.00162	CcSEcCtD
Toremifene—Malnutrition—Doxorubicin—thyroid cancer	0.000807	0.00161	CcSEcCtD
Toremifene—ESR1—Nuclear Receptor transcription pathway—RXRA—thyroid cancer	0.000804	0.0148	CbGpPWpGaD
Toremifene—Vertigo—Epirubicin—thyroid cancer	0.000784	0.00156	CcSEcCtD
Toremifene—Leukopenia—Epirubicin—thyroid cancer	0.000781	0.00155	CcSEcCtD
Toremifene—Back pain—Doxorubicin—thyroid cancer	0.000781	0.00155	CcSEcCtD
Toremifene—Vision blurred—Doxorubicin—thyroid cancer	0.000761	0.00151	CcSEcCtD
Toremifene—Chest pain—Epirubicin—thyroid cancer	0.000743	0.00148	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000738	0.00147	CcSEcCtD
Toremifene—Vertigo—Doxorubicin—thyroid cancer	0.000725	0.00144	CcSEcCtD
Toremifene—Leukopenia—Doxorubicin—thyroid cancer	0.000723	0.00144	CcSEcCtD
Toremifene—Oedema—Epirubicin—thyroid cancer	0.000712	0.00142	CcSEcCtD
Toremifene—Nervous system disorder—Epirubicin—thyroid cancer	0.000698	0.00139	CcSEcCtD
Toremifene—Thrombocytopenia—Epirubicin—thyroid cancer	0.000697	0.00139	CcSEcCtD
Toremifene—Skin disorder—Epirubicin—thyroid cancer	0.000692	0.00138	CcSEcCtD
Toremifene—Hyperhidrosis—Epirubicin—thyroid cancer	0.000688	0.00137	CcSEcCtD
Toremifene—Chest pain—Doxorubicin—thyroid cancer	0.000687	0.00137	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000683	0.00136	CcSEcCtD
Toremifene—CYP1A1—Metapathway biotransformation—CHST14—thyroid cancer	0.000682	0.0126	CbGpPWpGaD
Toremifene—Anorexia—Epirubicin—thyroid cancer	0.000679	0.00135	CcSEcCtD
Toremifene—ESR1—AP-1 transcription factor network—CDK1—thyroid cancer	0.000672	0.0124	CbGpPWpGaD
Toremifene—Oedema—Doxorubicin—thyroid cancer	0.000659	0.00131	CcSEcCtD
Toremifene—Nervous system disorder—Doxorubicin—thyroid cancer	0.000646	0.00129	CcSEcCtD
Toremifene—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000645	0.00128	CcSEcCtD
Toremifene—Insomnia—Epirubicin—thyroid cancer	0.000644	0.00128	CcSEcCtD
Toremifene—ESR1—Nuclear Receptors—PPARG—thyroid cancer	0.000642	0.0118	CbGpPWpGaD
Toremifene—Skin disorder—Doxorubicin—thyroid cancer	0.00064	0.00127	CcSEcCtD
Toremifene—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000637	0.00127	CcSEcCtD
Toremifene—Dyspnoea—Epirubicin—thyroid cancer	0.000635	0.00126	CcSEcCtD
Toremifene—Anorexia—Doxorubicin—thyroid cancer	0.000628	0.00125	CcSEcCtD
Toremifene—Decreased appetite—Epirubicin—thyroid cancer	0.000619	0.00123	CcSEcCtD
Toremifene—ABCB1—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000617	0.0114	CbGpPWpGaD
Toremifene—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000615	0.00122	CcSEcCtD
Toremifene—Fatigue—Epirubicin—thyroid cancer	0.000614	0.00122	CcSEcCtD
Toremifene—Constipation—Epirubicin—thyroid cancer	0.000609	0.00121	CcSEcCtD
Toremifene—Pain—Epirubicin—thyroid cancer	0.000609	0.00121	CcSEcCtD
Toremifene—Insomnia—Doxorubicin—thyroid cancer	0.000596	0.00119	CcSEcCtD
Toremifene—Dyspnoea—Doxorubicin—thyroid cancer	0.000587	0.00117	CcSEcCtD
Toremifene—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—thyroid cancer	0.000577	0.0106	CbGpPWpGaD
Toremifene—Decreased appetite—Doxorubicin—thyroid cancer	0.000573	0.00114	CcSEcCtD
Toremifene—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000569	0.00113	CcSEcCtD
Toremifene—Fatigue—Doxorubicin—thyroid cancer	0.000568	0.00113	CcSEcCtD
Toremifene—Constipation—Doxorubicin—thyroid cancer	0.000563	0.00112	CcSEcCtD
Toremifene—Pain—Doxorubicin—thyroid cancer	0.000563	0.00112	CcSEcCtD
Toremifene—ABCB1—HIF-1-alpha transcription factor network—CP—thyroid cancer	0.00055	0.0101	CbGpPWpGaD
Toremifene—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—thyroid cancer	0.000548	0.0101	CbGpPWpGaD
Toremifene—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—thyroid cancer	0.000539	0.00993	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—TPR—thyroid cancer	0.000536	0.00987	CbGpPWpGaD
Toremifene—Asthenia—Epirubicin—thyroid cancer	0.000511	0.00102	CcSEcCtD
Toremifene—ESR1—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.000507	0.00934	CbGpPWpGaD
Toremifene—Pruritus—Epirubicin—thyroid cancer	0.000504	0.001	CcSEcCtD
Toremifene—ESR1—Regulation of Telomerase—TERT—thyroid cancer	0.000496	0.00913	CbGpPWpGaD
Toremifene—Asthenia—Doxorubicin—thyroid cancer	0.000473	0.000941	CcSEcCtD
Toremifene—Dizziness—Epirubicin—thyroid cancer	0.000471	0.000937	CcSEcCtD
Toremifene—CYP1A1—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000467	0.0086	CbGpPWpGaD
Toremifene—Pruritus—Doxorubicin—thyroid cancer	0.000466	0.000927	CcSEcCtD
Toremifene—ESR1—AP-1 transcription factor network—HIF1A—thyroid cancer	0.000463	0.00853	CbGpPWpGaD
Toremifene—Vomiting—Epirubicin—thyroid cancer	0.000453	0.000901	CcSEcCtD
Toremifene—ESR1—Generic Transcription Pathway—TRIM33—thyroid cancer	0.000452	0.00832	CbGpPWpGaD
Toremifene—Rash—Epirubicin—thyroid cancer	0.000449	0.000893	CcSEcCtD
Toremifene—Dermatitis—Epirubicin—thyroid cancer	0.000449	0.000892	CcSEcCtD
Toremifene—Headache—Epirubicin—thyroid cancer	0.000446	0.000888	CcSEcCtD
Toremifene—Dizziness—Doxorubicin—thyroid cancer	0.000436	0.000867	CcSEcCtD
Toremifene—CYP1A2—Metapathway biotransformation—CHST14—thyroid cancer	0.000435	0.008	CbGpPWpGaD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	0.000433	0.00798	CbGpPWpGaD
Toremifene—ABCB1—HIF-1-alpha transcription factor network—EPO—thyroid cancer	0.000432	0.00795	CbGpPWpGaD
Toremifene—Nausea—Epirubicin—thyroid cancer	0.000423	0.000842	CcSEcCtD
Toremifene—ESR1—FOXM1 transcription factor network—CCND1—thyroid cancer	0.000421	0.00775	CbGpPWpGaD
Toremifene—Vomiting—Doxorubicin—thyroid cancer	0.000419	0.000833	CcSEcCtD
Toremifene—Rash—Doxorubicin—thyroid cancer	0.000415	0.000827	CcSEcCtD
Toremifene—Dermatitis—Doxorubicin—thyroid cancer	0.000415	0.000826	CcSEcCtD
Toremifene—Headache—Doxorubicin—thyroid cancer	0.000413	0.000821	CcSEcCtD
Toremifene—Nausea—Doxorubicin—thyroid cancer	0.000391	0.000779	CcSEcCtD
Toremifene—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.00038	0.007	CbGpPWpGaD
Toremifene—ESR1—Estrogen signaling pathway—AKT1—thyroid cancer	0.000379	0.00698	CbGpPWpGaD
Toremifene—CYP1A1—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000379	0.00698	CbGpPWpGaD
Toremifene—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000371	0.00684	CbGpPWpGaD
Toremifene—ESR1—Plasma membrane estrogen receptor signaling—NRAS—thyroid cancer	0.00037	0.00681	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—CDK1—thyroid cancer	0.000361	0.00665	CbGpPWpGaD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	0.000337	0.00621	CbGpPWpGaD
Toremifene—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	0.000335	0.00618	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—THRB—thyroid cancer	0.000327	0.00601	CbGpPWpGaD
Toremifene—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—thyroid cancer	0.000321	0.00591	CbGpPWpGaD
Toremifene—ESR1—ATF-2 transcription factor network—CCND1—thyroid cancer	0.000321	0.00591	CbGpPWpGaD
Toremifene—ESR1—Plasma membrane estrogen receptor signaling—KRAS—thyroid cancer	0.000318	0.00586	CbGpPWpGaD
Toremifene—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—thyroid cancer	0.000301	0.00554	CbGpPWpGaD
Toremifene—CYP1A2—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000298	0.00549	CbGpPWpGaD
Toremifene—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000296	0.00546	CbGpPWpGaD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	0.00029	0.00534	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—NRG1—thyroid cancer	0.00029	0.00534	CbGpPWpGaD
Toremifene—CYP1A1—PPARA activates gene expression—RXRA—thyroid cancer	0.000288	0.0053	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	0.000287	0.00529	CbGpPWpGaD
Toremifene—ESR1—Regulation of Telomerase—CCND1—thyroid cancer	0.000286	0.00527	CbGpPWpGaD
Toremifene—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—RXRA—thyroid cancer	0.000282	0.00519	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—CCND1—thyroid cancer	0.00028	0.00515	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.000279	0.00514	CbGpPWpGaD
Toremifene—ESR1—LKB1 signaling events—TP53—thyroid cancer	0.000272	0.00501	CbGpPWpGaD
Toremifene—ESR1—Plasma membrane estrogen receptor signaling—HRAS—thyroid cancer	0.000271	0.00498	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—PTEN—thyroid cancer	0.00027	0.00497	CbGpPWpGaD
Toremifene—CYP1A1—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000269	0.00495	CbGpPWpGaD
Toremifene—ABCB1—HIF-1-alpha transcription factor network—TERT—thyroid cancer	0.000269	0.00494	CbGpPWpGaD
Toremifene—ESR1—Leptin signaling pathway—CCND1—thyroid cancer	0.000265	0.00488	CbGpPWpGaD
Toremifene—ABCB1—HIF-1-alpha transcription factor network—HIF1A—thyroid cancer	0.000257	0.00473	CbGpPWpGaD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	0.000247	0.00454	CbGpPWpGaD
Toremifene—CYP1A2—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000242	0.00445	CbGpPWpGaD
Toremifene—ESR1—Plasma membrane estrogen receptor signaling—AKT1—thyroid cancer	0.000239	0.0044	CbGpPWpGaD
Toremifene—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.00023	0.00423	CbGpPWpGaD
Toremifene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000229	0.00421	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	0.000223	0.00411	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—TRIM33—thyroid cancer	0.000218	0.00401	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000214	0.00394	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—MEN1—thyroid cancer	0.000207	0.00382	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—BRAF—thyroid cancer	0.000207	0.00382	CbGpPWpGaD
Toremifene—CYP1A1—Biological oxidations—RXRA—thyroid cancer	0.000201	0.00371	CbGpPWpGaD
Toremifene—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—RXRA—thyroid cancer	0.000194	0.00357	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	0.000192	0.00354	CbGpPWpGaD
Toremifene—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000186	0.00343	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—TP53—thyroid cancer	0.000184	0.00339	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	0.000183	0.00337	CbGpPWpGaD
Toremifene—CYP1A1—PPARA activates gene expression—PPARG—thyroid cancer	0.000182	0.00335	CbGpPWpGaD
Toremifene—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—thyroid cancer	0.000178	0.00327	CbGpPWpGaD
Toremifene—CYP1A2—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000171	0.00315	CbGpPWpGaD
Toremifene—ESR1—Leptin signaling pathway—HRAS—thyroid cancer	0.000167	0.00307	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	0.000163	0.00301	CbGpPWpGaD
Toremifene—ESR1—Regulation of Telomerase—AKT1—thyroid cancer	0.000159	0.00293	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—THRB—thyroid cancer	0.000157	0.0029	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—CCND1—thyroid cancer	0.000151	0.00279	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CALCB—thyroid cancer	0.000149	0.00275	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—MINPP1—thyroid cancer	0.000148	0.00272	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.000148	0.00272	CbGpPWpGaD
Toremifene—ESR1—Leptin signaling pathway—AKT1—thyroid cancer	0.000147	0.00271	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—PTEN—thyroid cancer	0.000146	0.00269	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—PTEN—thyroid cancer	0.000145	0.00267	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	0.000142	0.00262	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TRIM33—thyroid cancer	0.000141	0.0026	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—RXRA—thyroid cancer	0.000139	0.00256	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	0.000139	0.00255	CbGpPWpGaD
Toremifene—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—thyroid cancer	0.000139	0.00255	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000136	0.00251	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—NRAS—thyroid cancer	0.00013	0.00239	CbGpPWpGaD
Toremifene—CYP1A2—Biological oxidations—RXRA—thyroid cancer	0.000128	0.00236	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—NDUFA13—thyroid cancer	0.000126	0.00231	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	0.000125	0.00231	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	0.000123	0.00226	CbGpPWpGaD
Toremifene—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—thyroid cancer	0.000123	0.00226	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	0.000121	0.00223	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CHST14—thyroid cancer	0.000118	0.00218	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—MINPP1—thyroid cancer	0.000118	0.00217	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—KRAS—thyroid cancer	0.000112	0.00206	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—KRAS—thyroid cancer	0.000112	0.00205	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—TPR—thyroid cancer	0.000106	0.00196	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	0.000104	0.00192	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—NDUFA13—thyroid cancer	0.0001	0.00185	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—MEN1—thyroid cancer	9.99e-05	0.00184	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—TP53—thyroid cancer	9.97e-05	0.00184	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—RXRA—thyroid cancer	9.9e-05	0.00182	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—HPGD—thyroid cancer	9.53e-05	0.00175	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—HRAS—thyroid cancer	9.48e-05	0.00175	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CHST14—thyroid cancer	9.44e-05	0.00174	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TCF7L1—thyroid cancer	9.44e-05	0.00174	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—MINPP1—thyroid cancer	9.43e-05	0.00174	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	9.33e-05	0.00172	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	9.33e-05	0.00172	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	9.29e-05	0.00171	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	9.18e-05	0.00169	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—PPARG—thyroid cancer	8.76e-05	0.00161	CbGpPWpGaD
Toremifene—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	8.63e-05	0.00159	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—AKT1—thyroid cancer	8.42e-05	0.00155	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—AKT1—thyroid cancer	8.37e-05	0.00154	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	8.26e-05	0.00152	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—NDUFA13—thyroid cancer	8.02e-05	0.00148	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	7.73e-05	0.00142	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—HPGD—thyroid cancer	7.61e-05	0.0014	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CHST14—thyroid cancer	7.54e-05	0.00139	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	7.34e-05	0.00135	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—MINPP1—thyroid cancer	7.28e-05	0.00134	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	6.99e-05	0.00129	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	6.97e-05	0.00128	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TSHR—thyroid cancer	6.91e-05	0.00127	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PRKAR1A—thyroid cancer	6.8e-05	0.00125	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—RXRA—thyroid cancer	6.68e-05	0.00123	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	6.63e-05	0.00122	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MEN1—thyroid cancer	6.49e-05	0.0012	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	6.4e-05	0.00118	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—NDUFA13—thyroid cancer	6.19e-05	0.00114	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—HPGD—thyroid cancer	6.08e-05	0.00112	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PTCH1—thyroid cancer	5.87e-05	0.00108	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	5.87e-05	0.00108	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CHST14—thyroid cancer	5.82e-05	0.00107	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—TPR—thyroid cancer	5.47e-05	0.00101	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PRKAR1A—thyroid cancer	5.38e-05	0.000991	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—SST—thyroid cancer	5.37e-05	0.000989	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CALCA—thyroid cancer	5.17e-05	0.000952	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	4.93e-05	0.000907	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	4.92e-05	0.000905	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	4.88e-05	0.000898	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—HPGD—thyroid cancer	4.69e-05	0.000863	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CDK1—thyroid cancer	4.68e-05	0.000862	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—TPR—thyroid cancer	4.37e-05	0.000805	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	4.37e-05	0.000805	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PRKAR1A—thyroid cancer	4.3e-05	0.000792	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—PPARG—thyroid cancer	4.22e-05	0.000777	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—SLC5A5—thyroid cancer	4.1e-05	0.000754	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.84e-05	0.000707	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NRG1—thyroid cancer	3.76e-05	0.000692	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	3.69e-05	0.000679	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—TPR—thyroid cancer	3.49e-05	0.000642	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—RXRA—thyroid cancer	3.44e-05	0.000634	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	3.43e-05	0.000632	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TERT—thyroid cancer	3.37e-05	0.000621	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.35e-05	0.000616	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—SLC5A5—thyroid cancer	3.27e-05	0.000602	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HIF1A—thyroid cancer	3.23e-05	0.000594	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.11e-05	0.000573	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—RXRA—thyroid cancer	2.75e-05	0.000506	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—TPR—thyroid cancer	2.69e-05	0.000496	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—BRAF—thyroid cancer	2.67e-05	0.000492	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	2.65e-05	0.000488	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—SLC5A5—thyroid cancer	2.61e-05	0.000481	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.45e-05	0.000451	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—RXRA—thyroid cancer	2.19e-05	0.000404	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PPARG—thyroid cancer	2.17e-05	0.0004	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.13e-05	0.000393	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—SLC5A5—thyroid cancer	2.02e-05	0.000371	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CCND1—thyroid cancer	1.95e-05	0.000359	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PTEN—thyroid cancer	1.88e-05	0.000346	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PPARG—thyroid cancer	1.74e-05	0.00032	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PTGS2—thyroid cancer	1.71e-05	0.000315	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—RXRA—thyroid cancer	1.69e-05	0.000312	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NRAS—thyroid cancer	1.68e-05	0.000309	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—AKT1—thyroid cancer	1.67e-05	0.000307	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PTEN—thyroid cancer	1.49e-05	0.000274	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—KRAS—thyroid cancer	1.45e-05	0.000266	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PPARG—thyroid cancer	1.39e-05	0.000255	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PTGS2—thyroid cancer	1.37e-05	0.000251	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TP53—thyroid cancer	1.28e-05	0.000236	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HRAS—thyroid cancer	1.23e-05	0.000226	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PTEN—thyroid cancer	1.19e-05	0.000219	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PTGS2—thyroid cancer	1.09e-05	0.000201	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—AKT1—thyroid cancer	1.08e-05	0.0002	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PPARG—thyroid cancer	1.07e-05	0.000197	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PTEN—thyroid cancer	9.51e-06	0.000175	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—AKT1—thyroid cancer	8.59e-06	0.000158	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PTGS2—thyroid cancer	8.41e-06	0.000155	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PTEN—thyroid cancer	7.34e-06	0.000135	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—AKT1—thyroid cancer	6.86e-06	0.000126	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—AKT1—thyroid cancer	5.48e-06	0.000101	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—AKT1—thyroid cancer	4.23e-06	7.78e-05	CbGpPWpGaD
